National Center for Complementary and Alternative Medicine (NCCAM), National Institutes of Health, Bethesda, MD, USA.
Philos Trans R Soc Lond B Biol Sci. 2011 Jun 27;366(1572):1922-30. doi: 10.1098/rstb.2010.0399.
Laboratory research recently has greatly enhanced the understanding of placebo and nocebo effects by identifying specific neuromodulators and brain areas associated with them. However, little progress has been made in translating this knowledge into improved patient care. Here, we discuss the limitations in our knowledge about placebo (and nocebo) effects and the need for translational research with the aim of guiding physicians in maximizing placebo effects and minimizing nocebo effects in their routine clinical practice. We suggest some strategies for how, when and why interventions to promote beneficial placebo responses might be administered in the clinical setting.
实验室研究最近通过确定与安慰剂和反安慰剂效应相关的特定神经调节剂和脑区,极大地增强了对这些效应的理解。然而,将这些知识转化为改善患者护理方面的进展甚微。在这里,我们讨论了我们对安慰剂(和反安慰剂)效应的知识的局限性,以及进行转化研究的必要性,旨在指导医生在日常临床实践中最大限度地发挥安慰剂效应,最小化反安慰剂效应。我们提出了一些策略,说明在临床环境中何时以及为何可以进行干预以促进有益的安慰剂反应。